We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current QURE market cap is 682.4M. The company's latest EPS is USD -6.3286 and P/E is -2.19.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 7.14M | 3.72M | 2.83M | 8.21M | 5.29M |
| Operating Income | -74.17M | -67.51M | -81.88M | -61.75M | -40.23M |
| Net Income | -77.23M | -68.47M | -89.57M | -73.21M | -44.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 9.17M | 40.86M | 536.31M | 113.65M | 21.9M |
| Operating Income | -123.97M | -125.43M | 310.62M | -143.16M | -282.87M |
| Net Income | -130.63M | -125.02M | 329.59M | -126.79M | -308.48M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 631M | 942.77M | 871.55M | 831.69M | 645.81M |
| Total Liabilities | 218.23M | 589.45M | 602.77M | 624.02M | 589.99M |
| Total Equity | 412.77M | 353.32M | 268.78M | 207.67M | 55.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 448.63M | 340.4M | 809.18M | 704.96M | 831.69M |
| Total Liabilities | 125.57M | 96.49M | 213.4M | 228.96M | 624.02M |
| Total Equity | 323.06M | 243.91M | 595.78M | 476.01M | 207.67M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -78.3M | -135.3M | -96.39M | -145.93M | -129.88M |
| Investing | 2.99M | 48.82M | -265.25M | -205.69M | 189.59M |
| Financing | 131k | 370.27M | 362.68M | 362.72M | -52.97M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -98.68M | -134.83M | 287.96M | -145.06M | -145.93M |
| Investing | -6.65M | -9.48M | -67.39M | -182.73M | -205.69M |
| Financing | 248.82M | 7.44M | 94.86M | 1.45M | 362.72M |
| Market Cap | 682.4M |
| Price to Earnings Ratio | -2.19 |
| Price to Sales Ratio | 30.83 |
| Price to Cash Ratio | 2.8 |
| Price to Book Ratio | 3.25 |
| Dividend Yield | - |
| Shares Outstanding | 48.74M |
| Average Volume (1 week) | 1.6M |
| Average Volume (1 Month) | 1.58M |
| 52 Week Change | 111.48% |
| 52 Week High | 19.18 |
| 52 Week Low | 3.73 |
| Spread (Intraday) | 0.22 (1.56%) |
| Company Name | uniQure NV |
| Address |
paasheuvelweg 25a amsterdam, north holland 1105 BP |
| Website | https://www.uniqure.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
